4/A//SEC Filing
Gayer Charles K 4/A
Accession 0001127602-22-001454
CIK 0000882796other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 4:38 PM ET
Size
4.7 KB
Accession
0001127602-22-001454
Insider Transaction Report
Form 4/AAmended
Gayer Charles K
Vice President and CCO
Transactions
- Award
Common Stock
2021-12-14+80,000→ 216,556 total
Footnotes (1)
- [F1]The number of restricted stock units awarded to the reporting person on December 14, 2021 was overstated in the original Form 4 due to an administrative error. This amendment corrects the error and reflects the corrected amount of restricted stock units awarded to the reporting person on such date.
Documents
Issuer
BIOCRYST PHARMACEUTICALS INC
CIK 0000882796
Entity typeother
Related Parties
1- filerCIK 0001800110
Filing Metadata
- Form type
- 4/A
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 4:38 PM ET
- Size
- 4.7 KB